3 Corsi precongressuali: sono aperte le iscrizioni, a titolo gratuito.
Tutte le informazioni utili per la registrazione sono disponibili nella sezione Iscrizioni del sito.
New frontiers in medical virology
Chairs: I. Bon (Bologna), B. Rossetti (Siena), C. Tincati (Milano)
Infectious diseases are of public interest because of their impact on human, animal, and plant health. In this context, viruses play a central role in all aspects of medical research, ranging from molecular biology and immunology to evolution and epidemiology. The course will offer insight into the laboratory tools for the surveillance, diagnosis and monitoring of viral infections. It will also focus on novel aspects of viral pathogenesis and elaboration of therapeutic strategies.
|14.00 - 14.10||Next-generation sequencing: a methodology changing the way to understand genome sequencing, evolution, ecology and discovery viruses||Nicola Clementi, Milano|
|14.10 - 14.20||Serological and molecular tools for detection of emerging viruses||Giada Rossini, Bologna|
|14.20 - 14.30||Role of HIV-1 protein variants in lymphoma pathogenesis||Francesca Caccuri, Brescia|
|14.30 - 14.40||New frontiers of antiviral strategies||Ombretta Turriziani, Roma|
|14.40 - 15.00||Discussion and conclusions|
New challenges in sexually transmitted infections: sexual health, prevention and more
Chairs: L. Badia (Bologna), G. Cuomo (Modena), R. Rossotti (Milano)
The consequences of sexually transmitted infections (STIs) on both individual and public health can be severe. The increasing incidence of STIs demands a call to action to ensure that populations at risk have access to comprehensive STIs prevention and care, especially in the context of expanded use of pre-exposure prophylaxis (PrEP) for HIV prevention. Integration of STIs services and PrEP is challenging but also provides a unique opportunity to optimize broader sexual and reproductive health services.
|15.00 - 15.10||Beyond PrEP: from a clinical management of STIs to a broader approach to sexual health||Maddalena Cordioli, Verona|
|15.10 - 15.20||Test and Same Day Treatment in HIV: the role of screening and early ART initiation in the management of HIV||Arturo Ciccullo, Roma|
|15.20 - 15.30||Empowering people for their sexual health: how U=U changed the sexual lives of people living with HIV||Daniele Calzavara, Milano|
|15.30 - 15.40||Focus on vaccinations: are they an effective tool of sexual prevention?||Margherita Digaetano, Modena|
|15.40 - 16.00||Discussion and conclusions|
Nurse management of patients with comorbidities
Chairs: E. Bruni (Ferrara), M. Gatti (Lecco), S. Patrucco (Torino)
Achieving an undetectable viral load is no longer the sole endpoint in treating HIV. Today’s challenge is to guide patients towards a proactive management of HIV-associated comorbidities. Therapies have improved notably: nowadays patients diagnosed with HIV and treated with the latest antiretrovirals have a life expectancy comparable to the general population. A recent study showed that in 2010 patients’ mean age was 43.9 years, whereas in 2030 is expected to be 56.6 years, with patients aged over 50 increasing from 28% to 73%. Nonetheless, there are more challenges to face: aging with HIV puts patients to an increased risk of developing HIVrelated illnesses, such as osteoporosis, hepatic, cardiovascular and neurological disease. It is therefore necessary for the nursing staff to be to able to lead patients to a successful management of their comorbidities through a learning process based on efficient means of communication aimed at patients’ empowerment.
|15.00 - 15.10||Cardiovascular risk factors|
|15.10 - 15.20||Nurse management of frail and elderly HIV-positive patients||Manuela Gatti, Lecco|
|15.20 - 15.30||Therapeutic Patient Education in subjects with neurocognitive disorders||Gian Piero Oliva, Roma|
|15.30 - 15.40||Nurse management of cancer patients||Adriana Meda, Monza|
|15.40 - 15.50||The nurse’s role in managing the risk of infection in HIV-positive patients||Erika Bruni, Ferrara|
|15.50 - 16.00||Discussion|